How can we ensure cell and gene therapies are truly transformative for patients? Success depends on the right combination of formulation, preparation, and delivery.
- How Can We Develop New Treatments For Patients With Early Breast Cancer?
- M&A In GLP-1 Technology: Practical Recommendations And Best Practices
- Drug Delivery Innovation: Getting Advanced Therapies To Patients
- Video Spotlight: Where Science Meets Magic with MIT Institute Professor Robert S. Langer
- Developing Exosome-Based RNA Therapeutics For CNS Regeneration
- CMC For Long-Acting Injectables For TB
- Drug Delivery Product Strategy: Aligning The Organization For Execution
- EU MDR: When Products Without An Intended Medical Purpose Meet Medicinal Substances
ON-DEMAND WEBINARS
Launching a large molecule in one format and then switching the delivery format often transpires as a lifecycle management strategy for cost efficiency, supply chain continuity, and patient benefit.
Intranasal drug delivery offers a promising route for administering medications, but advancing to market can be a difficult journey. Learn about common development pitfalls and how to mitigate risk.
Strengthen risk mitigation strategies while ensuring regulatory alignment. Gain valuable insights into best practices and proactive approaches for building a robust and future-ready CCS.
In this webinar, experts examine how the right combination of advanced technology and specialized expertise can leverage micronization to address the challenges often faced by small molecule drugs.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![iStock-1278412677-oncology-cancer-patient]( "Accelerating The Development Of Oncology Medicines")
Accelerating The Development Of Oncology MedicinesOncology drug development has seen a significant shift in focus, as molecule chemistries and drug technologies have improved. Explore five areas for consideration and the potential emerging solutions.
-
![GettyImages-1354171846-lab-research-development]( "Propelling Gene Therapies From Lab To Clinic")
Propelling Gene Therapies From Lab To ClinicMany companies are turning to CDMOs to optimize biomanufacturing processes and address the growing list of complications on the path to commercialization.
-
![magnifying glass w pills 450x300]( "Analyzing Product Formulation Using Raman Microscopy")
Analyzing Product Formulation Using Raman MicroscopyRaman spectroscopy is used to compare the dissolution rates and pellet fine structure of branded Sporanox® with three similar generic products marketed across the world, all containing the same API.
-
![biotechnology-molecular engineering-DNA Genetic Manipulation-GettyImages-1310118370]( "Hosts For Vaccine And Virus Expression: Insect Cell Expression Systems")
Hosts For Vaccine And Virus Expression: Insect Cell Expression SystemsChoosing the right host is key to creating scalable, robust, and reliable commercial processes. Explore common challenges associated with the insect cell culture/baculovirus expression vector systems platform.
-
![Assessing And Navigating Testing For Parenteral Packaging And Delivery Systems: Performance Testing]( "Best Practices For Ensuring Quality In Biologic Products")
Best Practices For Ensuring Quality In Biologic ProductsNew biologic therapies have new challenges in their packaging and delivery systems because of their complexities, higher stability risks, and larger sizes.
-
![BD2]( "Leveraging Autoinjector Innovation To De-Risk Biosimilar Development")
Leveraging Autoinjector Innovation To De-Risk Biosimilar DevelopmentDiscover how a biopharmaceutical company can de-risk the launch process by choosing a suitable autoinjector technology and partner.
-
![GettyImages-1284529278-syringe-pre-filled-PFS]( "New Perspectives On Accelerating Genetic Nanomedicines Through The Regulatory Pathway")
New Perspectives On Accelerating Genetic Nanomedicines Through The Regulatory PathwayDiscover how regulatory bodies are adopting a risk-based approach to address the unique challenges of genetic nanomedicines, and stakeholder engagement is essential.
-
![SIS_SelfDose_042 _1252_RGB]( "How Subcutaneous Delivery Can Help Patients Manage Chronic Conditions")
How Subcutaneous Delivery Can Help Patients Manage Chronic ConditionsRead more about how to improve your patients’ outcomes, avoid costly delays to launch, and provide a better return on investment.
-
![GettyImages-1027752634]( "Selecting An Alternative Coating Technology To Silicone Oil For Prefillable Syringes")
Selecting An Alternative Coating Technology To Silicone Oil For Prefillable SyringesThe challenges of silicone-oil lubrication and the growing trend for more viscous, protein-based drugs are now leading pharma and biotech companies to investigate alternative solutions.
-
![GettyImages-1346675513 lab materials]( "Early Solid Form Screening To Guide Drug Development")
Early Solid Form Screening To Guide Drug DevelopmentConducting solid form screening early can help your team select and isolate the ideal lead polymorph to ensure manufacturability and stability while avoiding costs and hiccups down the road.
Tom hosts multiple videocast series providing expert takes and insider perspectives on drug delivery:
In her monthly column, Fran offers keen industry insights exclusively on Drug Delivery Leader.
FRANKLY FRAN
-
![frankly-fran-better]( "Drug Delivery Innovation: Getting Advanced Therapies To Patients")
In this article, Fran DeGrazio recounts the evolution of drug delivery technologies as she underscores the need to innovate in the delivery of advanced therapies. Considering chronic diseases, rare diseases, and difficult-to-reach therapeutic targets, Fran offers suggestions for organizing and readying for the development and delivery of platforms, systems, and devices for next generation treatments, including personalized, precision medicines.
FREE EBOOK: COMBINATION PRODUCTS
Combination products provide significant avenues for increasing patient adherence and overall efficacy. This collection outlines the opportunity and identifies strategies for gaining regulatory approval.
